Induction immunosuppression is intense, prophylactic therapy used at the time of
transplantation based on the empiric observation that more powerful immunosuppression is …

Background. Induction agents have been shown to reduce the rate of acute rejection. They
have not been clearly shown to improve graft and patient survival. Methods. United Network …

BACKGROUND: Solid organ transplant centers are increasingly using induction
immunosuppression strategies. Induction immunosuppression involves the use of intense …

Purpose Induction immunosuppressive therapies for patients undergoing renal
transplantation are reviewed. Summary The goal of induction therapy is to prevent acute …

Currently available immunosuppressive agents can be classified into three categories:
induction agents, maintenance therapy, and treatment for rejection. This review article will …

BACKGROUND: Induction immunosuppression utilizing lymphocytolytic agents in the early
peri-operative period has a number of theoretical and practical advantages and …

Current concerns in pediatric transplantation focus on chronic rejection which commonly
leads to graft loss, and on long‐term maintenance immunosuppression toxicity. Acute …

Immunosuppression remains the cause of most morbidity following organ transplantation.
However, its use is also responsible for the outstanding graft and patient survival rates …

The present success of organ transplantation is largely due to advances in
immunosuppressive therapy. Progress has been made from a cytotoxic strategy associated …

New immunosuppressants and the better use of immunosuppressant combination therapy
have led to significant improvements in renal allograft outcomes over the last decades. Yet …